Nurse Practitioner in Mission, SD Accepting Medicare
4 Nurse Practitioner nurses found. Showing 1 - 4
 Briana Broschat, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 161 Main St, Mission, SD 57555 Phone: 856-605-2295 |
Mrs. Autumn Rae Tucker, CNP Nurse Practitioner - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 161 S, Main Street, Mission, SD 57555 Phone: 605-856-2295 |
 Ryan Ross Rowe, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 161 S. Main, Mission, SD 57555 Phone: 605-856-2295 |
Alyssa Morgan Hicks, CNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 161 S Main Street, Mission, SD 57555 Phone: 605-856-2295 Fax: 866-423-6811 |
News Archive
CTRC starts enrolment in Phase 2 combination trial of REOLYSIN and gemcitabine for advanced pancreatic cancer
Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center in San Antonio (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with gemcitabine (Gemzar(R)) in patients with advanced pancreatic cancer. The Principal Investigator is Dr. Monica Mita of the CTRC.
New optogenetic manipulation technique could possibly reduce migraine headaches
Despite decades of research, migraines are often not well controlled with medication. For those prone to this type of debilitating headache, it sometimes seems nothing can stop the pain and the sensitivity to light. But what if light itself was key to their relief?
Generic drug delays cost U.S. payers millions
Problems surrounding an Indian company's launch of generic versions of three blockbuster drugs have preserved millions in revenue for the brand-name makers, reports The Wall Street Journal.
IRSF announces first 2010 ANGEL Grant for testing potential Rett Syndrome therapies
Today, the International Rett Syndrome Foundation (IRSF) announced that it will commit $446,000 in 2010 to fund a large translational research program to test potential therapeutics for Rett Syndrome in mouse models of the disease. The funds will be awarded through the IRSF's new Advanced Neurotherapeutic Grant of Excellence (ANGEL) mechanism which seeks to provide funds for translational research. IRSF is the world's largest private source of Rett syndrome research funding, supporting nearly $21 million in research programs to date. This is the first ANGEL Grant supported by IRSF in 2010.
› Verified 1 days ago